| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/01/2011 | US7897342 Kit for identifying mobile genetic element insertional event which subsequently generates insect resistant monocot crop plant |
| 03/01/2011 | US7897341 Optical sorting method |
| 03/01/2011 | US7897340 Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker |
| 03/01/2011 | US7897338 Mobility-modified nucleobase polymers and methods of using same |
| 03/01/2011 | US7897337 Method for performing multi-formatted assays |
| 03/01/2011 | US7897336 Using a dye or radioactive tracer in conjunction with nucleic acid marker; cancer diagnosis and prognosis; drug delivery, gene therapy, activation of tumor immunity and inhibiting metastasis |
| 03/01/2011 | US7897335 Detection of preferential proteins in sample; obtain sample nucleotide sequences, dilute, amplify sequences, translate, test for proteins |
| 03/01/2011 | US7897334 Detecting profilaggrin alleles; natural moisturising factors (NMF); erythema; cosmetics; antiinflammatory agents |
| 03/01/2011 | US7897333 Reagent for measuring clotting time and method for manufacturing the reagent |
| 03/01/2011 | US7897332 Immunoglobulin for detecting lymphadenopathy associated viral infections; immunodiagnostics |
| 03/01/2011 | US7897331 Process of using a tetrazolium salt |
| 03/01/2011 | US7897330 Methods for characterizing enzyme inhibitors |
| 03/01/2011 | US7897329 predicting a lung cell cancer by detecting a URLC8 (up-regulated in lung cancer 8) expression level in a specimen; kit for detecting the ability of a test compound to modulate t-RNA dihydrouridine-synthase activity; biodrug for treating lung cancer |
| 03/01/2011 | CA2688760A1 Transformed human pluripotent stem cells and associated methods |
| 03/01/2011 | CA2644178C Rapid response glucose sensor |
| 03/01/2011 | CA2511042C Association of single nucleotide polymorphisms in ppar.gamma. with osteoporosis |
| 03/01/2011 | CA2469154C Cytotoxic protein and utilization thereof |
| 03/01/2011 | CA2400664C A method for generating hypermutable plants |
| 03/01/2011 | CA2323525C Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 03/01/2011 | CA2217820C Milk and milk products for preventing or treating heart disease |
| 02/28/2011 | CA2676946A1 Adam12 inhibitors and their use against inflammation-induced fibrosis |
| 02/24/2011 | WO2011022589A2 Detection of enterovirus |
| 02/24/2011 | WO2011022563A1 Pon1 as a marker for heart failure |
| 02/24/2011 | WO2011022542A2 Administration of factors normally present in a microbial niche to improve health |
| 02/24/2011 | WO2011022471A1 Detection of aad-1 event das-40278-9 |
| 02/24/2011 | WO2011022445A2 Improved multiplexed, microparticle-based assay for antibodies to antigens |
| 02/24/2011 | WO2011022420A1 Methylation biomarkers and methods of use |
| 02/24/2011 | WO2011022400A1 Electronic-chemometric controlled system and process for the analysis of analytes |
| 02/24/2011 | WO2011022228A2 Apparatus and method for enhanced disruption and extraction of intracellular materials from microbial cells |
| 02/24/2011 | WO2011022054A2 Diagnosing and managing venous thromboembolism and intracardiac thrombi using a provoked d-dimer test |
| 02/24/2011 | WO2011021846A2 Multi-spot metal-deposited nucleic acid chip with nanostructure arrays for diagnosing corneal dystrophy, and method for producing same |
| 02/24/2011 | WO2011021779A2 Method for evaluating water quality and toxicity using the growth rate of germ tubes of spores of algae belonging to the order laminariales |
| 02/24/2011 | WO2011021778A2 Method for evaluating water quality and toxicity using the germination rate of spores of algae belonging to the order laminariales, and kit for evaluating water quality and toxicity |
| 02/24/2011 | WO2011021666A1 Recombinant dna molecule encoding 5'utr capable of preventing inhibition of translation under environmental stresses |
| 02/24/2011 | WO2011021657A1 Method for quantification of l-lysine in biological sample |
| 02/24/2011 | WO2011021508A1 Marker for predicting therapeutic effect on hepatitis c, method for predicting therapeutic effect on hepatitis c, and prophylaxis or therapeutic agent for hepatitis c |
| 02/24/2011 | WO2011021391A1 Device for evaluating cultured cells, incubator, and program |
| 02/24/2011 | WO2011021386A1 Cstf2 for target genes of lung cancer therapy and diagnosis |
| 02/24/2011 | WO2011021381A1 Pharmaceutical composition containing anti-hb-egf antibody as active ingredient |
| 02/24/2011 | WO2011021177A2 Compositions and methods for prognosis and treatment of prostate cancer |
| 02/24/2011 | WO2011021008A1 Bioluminescent bacterial detection |
| 02/24/2011 | WO2011020926A1 Specific marker and method for detecting and identifying a legionella pneumophila serogroup 1 bacterium |
| 02/24/2011 | WO2011020906A2 sPLA2 IIA POLYMORPHISM ANALYSIS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT |
| 02/24/2011 | WO2011020865A1 Apolipoprotein l- i variants and their use |
| 02/24/2011 | WO2011020588A1 Method for detecting target nucleic acids |
| 02/24/2011 | WO2011020522A1 Method for determining the risk of metastasis as an indicator for diagnostic imaging |
| 02/24/2011 | WO2011020247A1 Replica barcode selection assay |
| 02/24/2011 | WO2011020198A1 Dna ligands for aflatoxin and zearalenone |
| 02/24/2011 | WO2011002862A3 Method and culture medium for enhanced detection of mycobacterium |
| 02/24/2011 | WO2011001135A9 Diagnosis and treatment of alzheimer's disease |
| 02/24/2011 | WO2010140827A9 Automatic detection kit for hla alleles by real-time polymerase chain reaction |
| 02/24/2011 | WO2010129919A9 Mirna expression in allergic disease |
| 02/24/2011 | WO2010120942A3 Histone modification patterns for clinical diagnosis and prognosis of cancer |
| 02/24/2011 | WO2010107946A3 Use of thermostable endonucleases for generating reporter molecules |
| 02/24/2011 | WO2010105235A3 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy |
| 02/24/2011 | WO2010104588A3 Compositions and methods for characterizing and treating neoplasia |
| 02/24/2011 | WO2010099127A3 Free circulating dna bio-markers and their applications |
| 02/24/2011 | WO2010093223A3 Target substance detection method using aptamer |
| 02/24/2011 | WO2010091235A3 Compositions, kits, and methods for determining plasmin activity |
| 02/24/2011 | WO2010083294A3 Diagnostics and therapeutics for osteoporosis |
| 02/24/2011 | WO2009088421A8 Non-invasive detection of bladder cancer by fluorescence in situ hybridization of aurora a |
| 02/24/2011 | WO2008015581A3 Three-dimensional physiological matrices for oncological testing and methods for their production and use |
| 02/24/2011 | WO2005121864A9 Optical lens system and method for microfluidic devices |
| 02/24/2011 | US20110047642 New cucumber plants with a compact growing habit |
| 02/24/2011 | US20110047634 Methods and compositions for the diagnosis and treatment of acute lymphoblastic leukemia |
| 02/24/2011 | US20110047633 Control of Exocrine Pancreatic Function Using Bone Morphogenetic Proteins |
| 02/24/2011 | US20110047631 Heat shock protein deficiencies as model systems for brain pathology and cancer |
| 02/24/2011 | US20110046982 Methods and compositions related to viral inhibition |
| 02/24/2011 | US20110046351 Mutant proteins and methods for selecting them |
| 02/24/2011 | US20110046207 C5a binding nucleic acids |
| 02/24/2011 | US20110046205 Method for dissolving charged nucleic acid in an organic liquid |
| 02/24/2011 | US20110046204 Human Zip1, Zinc and Citrate for Prostate Cancer Screening |
| 02/24/2011 | US20110046202 Method for testing a subject thought to have or to be predisposed to asthma |
| 02/24/2011 | US20110046201 Methods and compositions for seamless cloning of nucleic acid molecules |
| 02/24/2011 | US20110046187 Assessing congestive heart risk in patients treated or potentially to be treated with a peroxisome-proliferator-activator-receptor-gamma agonist or a thiazolidinedione |
| 02/24/2011 | US20110046094 Methods and compositions for identifying and treating lupus |
| 02/24/2011 | US20110046045 Method of treating obesity and metabolic disorders related to excess adipose tissue by administration of sFRP-5 peptide |
| 02/24/2011 | US20110046044 Use of a cysteine protease of Plasmodium vivax |
| 02/24/2011 | US20110046042 Long Interspersed Nuclear Element Polypeptide Compositions and Methods of Use Thereof |
| 02/24/2011 | US20110046020 Novel ion channel-forming peptides |
| 02/24/2011 | US20110046018 Sers-based, single step, real-time detection of protein kinase and/or phosphatase activity |
| 02/24/2011 | US20110046011 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof |
| 02/24/2011 | US20110046010 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 02/24/2011 | US20110046009 Methods for detecting dna methylation using encoded particles |
| 02/24/2011 | US20110046006 Means and methods for typing a cell isolate of an individual suffering from a psychiatric disorder or at risk of suffering there from |
| 02/24/2011 | US20110046005 Method and nucleic acids for the analysis of colon cell proliferative disorders |
| 02/24/2011 | US20110046000 Methods to increase the photostability of dyes |
| 02/24/2011 | US20110045998 Candidate genes and blood biomarkers for bipolar mood disorder, alcoholism and stress disorder |
| 02/24/2011 | US20110045996 Robust regression based exon array protocol system and applications |
| 02/24/2011 | US20110045992 Dna sequencing method and system |
| 02/24/2011 | US20110045991 Methods for the Detection of Colorectal Cancer |
| 02/24/2011 | US20110045589 Methods Of Controlling Proliferation And Differentiation Of Stem And Progenitor Cells |
| 02/24/2011 | US20110045573 Alanine 2, 3-aminomutase |
| 02/24/2011 | US20110045569 Enzymatic conversion of blood group a, b, and ab red blood cells using alpha-n- acetylgalactosaminidases and alpha-galactosidases with unique substrate specificities and kinetic properties |
| 02/24/2011 | US20110045541 Method of nucleic acid amplification |
| 02/24/2011 | US20110045527 Measurement of protein using inclusion body dry weight |
| 02/24/2011 | US20110045526 Selection of useful fungal strains |
| 02/24/2011 | US20110045525 Method for Flagging a Sample |
| 02/24/2011 | US20110045524 Transfection ready eukaryotic cells |
| 02/24/2011 | US20110045523 Optical Nanosensors Comprising Photoluminescent Nanostructures |